Nanostics

About:

Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.

Website: http://www.nanosticsdx.com

Twitter/X: nanostics

Top Investors: VA Angels, University of Alberta

Description:

Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.The company's technology combines a sensitive extracellular vesicle detection platform with advanced machine learning to diagnose disease and predict clinically significant prostate cancer from a simple blood test, enabling healthcare professionals to provide clarity to patients about their health by enabling better diagnosis and improving health care decisions.